Arbutus Biopharma Corp (ABUS) — Business segments and KPIs
Revenue by business segment and geography for Arbutus Biopharma Corp, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| License | 10.43M | 82.1% |
| Non-Cash Royalty | 1.48M | 11.7% |
| Service, Other | 800K | 6.3% |